Quantificare

San Mateo, United States Founded: 2001 • Age: 25 yrs
Provider of 3D imaging systems and clinical trial services for aesthetic and medical applications
Request Access

About Quantificare

Quantificare is a company based in San Mateo (United States) founded in 2001.. Quantificare has raised $5.49 million across 1 funding round from investors including LBO France. Quantificare offers products and services including LifeViz Mini Pro, LifeViz Infinity Pro, LifeViz Mini, LifeViz Infinity, and LifeViz Body. Quantificare operates in a competitive market with competitors including BioTelemetry, Oncodesign Services, Calyx, Molecular NeuroImaging and Imaging Endpoints, among others.

  • Headquarter San Mateo, United States
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Quantificare Inc.
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $5.49 M (USD)

    in 1 rounds

  • Latest Funding Round
    $5.49 M (USD), Series A

    Sep 03, 2019

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Quantificare

Quantificare offers a comprehensive portfolio of products and services, including LifeViz Mini Pro, LifeViz Infinity Pro, LifeViz Mini, LifeViz Infinity, and LifeViz Body. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

3D system for facial and body imaging in aesthetic practices.

Advanced 3D photography for detailed patient consultations.

Compact tool for aesthetic image capture and analysis.

3D imaging device for comprehensive body assessments.

Specialized system for body and breast imaging applications.

Micro-level 3D imaging for clinical trial evaluations.

Services for study setup and image analysis in trials.

People of Quantificare
Headcount 50-200
Employee Profiles 48
Employee Profiles
People
Théo Galano Kaminski
Marketing And Sales Manager - North America
People
Angéline Guisset
Marketing & Communication Specialist EMEA
People
Asma Bensouici
Clinical Project Manager II
People
Samia Lattaoui
Clinical Data Coordinator

Unlock access to complete

Funding Insights of Quantificare

Quantificare has successfully raised a total of $5.49M through 1 strategic funding round. The most recent funding activity was a Series A round of $5.49 million completed in September 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 1
  • Last Round Series A — $5.5M
  • First Round

    (03 Sep 2019)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Sep, 2019 Amount Series A - Quantificare Valuation LBO France
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Quantificare

Quantificare has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include LBO France. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
Private equity investments are made in France and the US.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Quantificare

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Quantificare

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Quantificare Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Quantificare

Quantificare operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BioTelemetry, Oncodesign Services, Calyx, Molecular NeuroImaging and Imaging Endpoints, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Wireless products for monitoring health parameters are offered.
domain founded_year HQ Location
CRO focused on oncology drugs discovery, bioanalysis, and preclinical services
domain founded_year HQ Location
CRO providing imaging services for clinical development
domain founded_year HQ Location
Company offering specialized imaging services for neurodegenerative and neuropsychiatric disorders
domain founded_year HQ Location
Offers medical imaging expertise for oncology research and clinical trials globally.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Quantificare

Frequently Asked Questions about Quantificare

When was Quantificare founded?

Quantificare was founded in 2001 and raised its 1st funding round 18 years after it was founded.

Where is Quantificare located?

Quantificare is headquartered in San Mateo, United States. It is registered at San Mateo, California, United States.

Is Quantificare a funded company?

Quantificare is a funded company, having raised a total of $5.49M across 1 funding round to date. The company's 1st funding round was a Series A of $5.49M, raised on Sep 03, 2019.

What does Quantificare do?

Provider of 3D imaging systems and clinical trial services for aesthetic and medical applications. It offers a suite of 3D cameras for aesthetic practitioners to capture and track patient progress. Additionally, it provides comprehensive clinical trial imaging services, including study setup, image management, analysis, and independent panel review. These services support pharmaceutical, biotechnology, and medical device companies in evaluating treatment efficacy and safety. The companys offerings are designed to standardize imaging processes and improve the accuracy of assessments in both clinical and aesthetic settings.

Who are the top competitors of Quantificare?

Quantificare's top competitors include BioTelemetry, Oncodesign Services and Calyx.

What products or services does Quantificare offer?

Quantificare offers LifeViz Mini Pro, LifeViz Infinity Pro, LifeViz Mini, LifeViz Infinity, and 3 more products and services.

Who are Quantificare's investors?

Quantificare has 1 investor. Key investors include LBO France.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available